Genomic & Biopharma NewsResearch opens treatment pathways for cancers that do not respond to targeted antibodies
By hijacking a cancer cell's own metabolism, researchers have found a way to tag and target elusive cancers with small-molecule sugars. This opens treatment pathways for cancers that are not responsive to conventional targeted antibodies, such as triple-negative breast cancer.
|News Medical Life Sciences, 2017-02-15 11:01:34|
ViiV study shows efficacy of two-drug HIV regimen
ViiV Healthcare has unveiled late-stage data showing that an experimental two-drug regimen of its dolutegravir and Janssen Science's rilpivirine was comparable in efficacy to three- or four-drug antiretroviral regimens in virologically suppressed patients.
|PharmaTimes, 2017-02-15 10:47:54|
Merck pulls plug on late-stage Alzheimer’s trial
Merck & Co has terminated a Phase II/III trial testing its investigational medicine verubecestat in patients with mild to moderate Alzheimer's disease.
|PharmaTimes, 2017-02-15 10:44:45|
Delivering STPs will need capital funding of £9.5bn, says BMA
An analysis by the British Medical Association has concluded that the NHS will need at least £9.5 billion of capital funding to pay for sustainability and transformation plans, which are currently being drawn up in 44 'footprint' areas with the aim of transforming and integrating health and social care services.
|PharmaTimes, 2017-02-15 10:41:00|
New review outlines key challenges and solutions to address growing burden of fragility fractures
With the first of the baby boomer generation now entering their eighties, the next decade will see a significant increase in the number of people living with osteoporosis and experiencing the often devastating outcome of fragility fractures.
|News Medical Life Sciences, 2017-02-15 10:29:24|
Rutgers-Princeton Center aims to improve diagnosis of psychiatric diseases using computational models
A new center is bringing together researchers from Princeton and Rutgers universities to apply computational modeling to the understanding of psychiatric diseases.
|News Medical Life Sciences, 2017-02-15 10:29:10|
Drug given to reduce side effects of pain medication may facilitate gastrointestinal recovery after testicular cancer surgery
Post-operative recovery and length of hospital stay are critical things to consider when having major surgery. A drug commonly given to reduce the side effects of strong post-surgery pain medications has been found to reduce the length of hospital stays for patients who have undergone major gastrointestinal or bladder cancer procedures.
|News Medical Life Sciences, 2017-02-15 10:28:33|
Smoking cessation counseling can be effective when given shortly after lung cancer screening
In the first successful randomized trial of its kind, researchers have provided preliminary evidence that telephone-based smoking cessation counseling given to smokers shortly after undergoing lung cancer screening can be effective at helping people stop smoking.
|News Medical Life Sciences, 2017-02-15 10:28:00|
Post-doc Position Available – Bio-medical Data Mining and Machine Learning
Universitätsklinikum Heidelberg – University Hospital Heidelberg The division of Bioinformatics and Systems Cardiology at the Klaus Tschira Institute for Integrative Computational Cardiology / Department of Internal Medicine III, seeks to fill one full-time position: Postdoc in Bio-medical Data Mining and Machine Learning (m/f) Starting date: 1 May 2017 / Duration: Initially 2 years; option of ...
|Transcriptome Research & Industry News, 2017-02-15 10:00:25|